Search results

Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia

Applied Molecular Therapies (AMT) has announced a successful TGA licence upgrade for the GMP manufacture of an emerging prostate cancer therapy, following the launch of a new joint venture between Cyclotek and ANSTO.

ANSTO has put together a robust multidisciplinary approach to understanding the impacts of nanomaterials, investigating a common food additive, E171 titanium dioxide, used primarily as a colouring agent in everyday foods. 

ANSTO researchers have demonstrated longstanding expertise in the study of nuclear fuel and radioactive waste with two recent journal articles in a special issue of Frontiers of Chemistry.

ANSTO researchers contribute to study which finds evidence of Aboriginal occupation 65,000 years ago in Northern Australia.

ANSTO has warmly welcomed the official launch of the Monash Precinct Network by Victorian Member for Ashwood, Matt Fregon MP at a special event at the Australian Synchrotron.

ANSTO has installed a radon detector for Curtin University in Burrup WA as part of the Murujuga Rock Art Monitoring Program

Dr Katie Sizeland, a Postdoctoral Fellow on the Small Angle X-ray Scattering beamline at the Australian Synchrotron, has been chosen for the Homeward Bound STEMM leadership program

ANSTO-nandin innovation hub win global hackathon challenge from NASA with COVID19 solution.

The independent nuclear regulator, ARPANSA, is currently accepting submissions about ANSTO’s planned $59.8 million Intermediate Level Solid Waste Storage Facility.

A large international research team led by Academia Sinica in Taiwan investigated how heat is transferred in an advanced thermoelectric material made with germanium (Ge) and tellurium (Te) and doped with antimony (Sb). These devices are used to power space probes such as the Mars Curiosity Rover.